Williams hematology
Williams hematology [electronic resource] /
Hematology. Williams hematology, Ninth edition
[edited by], Kenneth Kaushansky, Marshall A. Lichtman, Josef T. Prchal, Marcel Levi, Oliver W. Press, Linda J. Burns, Michael A. Caligiuri.
- 9th ed.
- New York, N.Y. : McGraw-Hill Education LLC., c2016.
- 1 online resource. : ill., figs., tables.
- McGraw-Hill's AccessMedicine A Lange medical book .
- McGraw-Hill's AccessMedicine. A Lange medical book. .
"A Lange medical book." Preceded by Williams hematology / editors, Kenneth Kaushansky... [et al.]. 8th ed. c2010.
Includes bibliographical references and indexes.
Chapter 63: Basophils, Mast Cells, and Related Disorders -- Chapter 64: Classification and Clinical Manifestations of Neutrophil Disorders -- Chapter 65: Neutropenia and Neutrophilia -- Chapter 66: Disorders of Neutrophil Function -- Part VIII: Monocytes and Macrophages -- Chapter 67: Structure, Receptors, and Functions of Monocytes and Macrophages -- Chapter 68: Production, Distribution, and Activation of Monocytes and Macrophages -- Chapter 69: Classification and Clinical Manifestations of Disorders of Monocytes and Macrophages -- Chapter 70: Monocytosis and Monocytopenia -- Chapter 71: Inflammatory and Malignant Histiocytosis -- Chapter 72: Gaucher Disease and Related Lysosomal Storage Diseases -- Part IX: Lymphocytes and Plasma Cells -- Chapter 73: The Structure of Lymphocytes and Plasma Cells -- Chapter 74: Lymphopoiesis -- Chapter 75: Functions of B Lymphocytes and Plasma Cells in Immunoglobulin Production -- Chapter 76: Functions of Tlymphocytes: T-Cell Receptors for Antigen -- Chapter 77: Functions of Natural Killer Cells -- Chapter 78: Classification and Clinical Manifestations of Lymphocyte and Plasma Cell Disorders -- Chapter 79: Lymphocytosis and Lymphocytopenia -- Chapter 80: Immunodeficiency Diseases -- Chapter 81: Hematologic Manifestations of Acquired Immunodeficiency Syndrome -- Chapter 82: Mononucleosis Syndromes -- Part X: Malignant Myeloid Diseases -- Chapter 83: Classification and Clinical Manifestations of the Clonal Myeloid Disorders -- Chapter 84: Polycythemia Vera -- Chapter 85: Essential Thrombocythemia -- Chapter 86: Primary Myelofibrosis -- Chapter 87: Myelodysplastic Syndromes -- Chapter 88: Acute Myelogenous Leukemia -- Chapter 89: Chronic Myelogenous Leukemia and Related Disorders -- Part XI: Malignant Lymphoid Diseases -- Chapter 90: Classification of Malignant Lymphoid Disorders -- Chapter 91: Acute Lymphoblastic Leukemia -- Chapter 92: Chronic Lymphocytic Leukemia -- Chapter 93: Hairy Cell Leukemia -- Chapter 94: Large Granular Lymphocytic Leukemia -- Chapter 95: General Considerations for Lymphomas: Epidemiology, Etiology, Heterogeneity, and Primary Extranodal Disease -- Chapter 96: Pathology of Lymphomas -- Chapter 97: Hodgkin Lymphoma -- Chapter 98: Diffuse Large B-Cell Lymphoma and Related Diseases -- Chapter 99: Follicular Lymphoma -- Chapter 100: Mantle Cell Lymphoma -- Chapter 101: Marginal Zone B-Cell Lymphomas -- Chapter 102: Burkitt Lymphoma -- Chapter 103: Cutaneous T-Cell Lymphoma (Mycosis Fungoides and SéZary Syndrome) -- Chapter 104: Mature T-Cell and Natural Killer Cell Lymphomas -- Chapter 105: Plasma Cell Neoplasms: General Considerations -- Chapter 106: Essential Monoclonal Gammopathy -- Chapter 107: Myeloma -- Chapter 108: Immunoglobulin Light-Chain Amyloidosis -- Chapter 109: Macroglobulinemia -- Chapter 110: Heavy-Chain Disease -- Part XII: Hemostasis and Thrombosis -- Chapter 111: Megakaryopoiesis and Thrombopoiesis -- Chapter 112: Platelet Morphology, Biochemistry, and Function -- Chapter 113: Molecular Biology and Biochemistry of the Coagulation Factors and Pathways of Hemostasis -- Chapter 114: Control of Coagulation Reactions -- Chapter 115: Vascular Function in Hemostasis -- Chapter 116: Classification, Clinical Manifestations, and Evaluation of Disorders of Hemostasis -- Chapter 117: Thrombocytopenia -- Chapter 118: Heparin-Induced Thrombocytopenia -- Chapter 119: Reactive Thrombocytosis -- Chapter 120: Hereditary Qualitative Platelet Disorders -- Chapter 121: Acquired Qualitative Platelet Disorders -- Chapter 122: The Vascular Purpuras -- Chapter 123: Hemophilia A and Hemophilia B -- Chapter 124: Inherited Deficiencies of Coagulation Factors II, V, V+VIII, VII, X, XI, and XIII -- Chapter 125: Hereditary Fibrinogen Abnormalities -- Chapter 126: Von Willebrand Disease -- Chapter 127: Antibody-Mediated Coagulation Factor Deficiencies -- Chapter 128: Hemostatic Alterations in Liver Disease and Liver Transplantation -- Chapter 129: Disseminated Intravascular Coagulation -- Chapter 130: Hereditary Thrombophilia -- Chapter 131: The Antiphospholipid Syndrome -- Chapter 132: Thrombotic Microangiopathies -- Chapter 133: Venous Thrombosis -- Chapter 134: Atherothrombosis: Disease Initiation, Progression, and Treatment -- Chapter 135: Fibrinolysis and Thrombolysis -- Part XIII: Transfusion Medicine -- Chapter 136: Erythrocyte Antigens and Antibodies -- Chapter 137: Human Leukocyte and Platelet Antigens -- Chapter 138: Blood Procurement and Red Cell Transfusion -- Chapter 139: Preservation and Clinical Use of Platelets. Part I: Clinical Evaluation of the Patient -- Chapter 1: Initial Approach to the Patient: History and Physical Examination -- Chapter 2: Examination of Blood Cells -- Chapter 3: Examination of the Marrow -- Chapter 4: Consultative Hematology -- Part II: The Organization of the Lymphohematopoietic Tissues -- Chapter 5: Structure of the Marrow and the Hematopoietic Microenvironment -- Chapter 6: The Organization and Structure of Lymphoid Tissues -- Part III: Epochal Hematology -- Chapter 7: Hematology of the Fetus and Newborn -- Chapter 8: Hematology During Pregnancy -- Chapter 9: Hematology in Older Persons -- Part IV: Molecular and Cellular Hematology -- Chapter 10: Genetic Principles and Molecular Biology -- Chapter 11: Genomics -- Chapter 12: Epigenetics -- Chapter 13: Cytogenetics and Genetic Abnormalities -- Chapter 14: Metabolism of Hematologic Neoplastic Cells -- Chapter 15: Apoptosis Mechanisms: Relevance to the Hematopoietic System -- Chapter 16: Cell-Cycle Regulation and Hematologic Disorders -- Chapter 17: Signal Transduction Pathways -- Chapter 18: Hematopoietic Stem Cells, Progenitors, and Cytokines -- Chapter 19: The Inflammatory Response -- Chapter 20: Innate Immunity -- Chapter 21: Dendritic Cells and Adaptive Immunity -- Part V: Therapeutic Principles -- Chapter 22: Pharmacology and Toxicity of Antineoplastic Drugs -- Chapter 23: Hematopoietic Cell Transplantation -- Chapter 24: Treatment of Infections in the Immunocompromised Host -- Chapter 25: Principles of Antithrombotic Therapy -- Chapter 26: Immune Cell Therapy -- Chapter 27: Vaccine Therapy -- Chapter 28: Therapeutic Apheresis: Indications, Efficacy, and Complications -- Chapter 29: Gene Therapy for Hematologic Diseases -- Chapter 30: Regenerative Medicine: Multipotential Cell Therapy for Tissue Repair -- Part VI: The Erythrocyte -- Chapter 31: Structure and Composition of the Erythrocyte -- Chapter 32: Erythropoiesis -- Chapter 33: Erythrocyte Turnover -- Chapter 34: Clinical Manifestations and Classification of Erythrocyte Disorders -- Chapter 35: Aplastic Anemia: Acquired and Inherited -- Chapter 36: Pure Red Cell Aplasia -- Chapter 37: Anemia of Chronic Disease -- Chapter 38: Erythropoietic Effects of Endocrine Disorders -- Chapter 39: The Congenital Dyserythropoietic Anemias -- Chapter 40: Paroxysmal Nocturnal Hemoglobinuria -- Chapter 41: Folate, Cobalamin, and Megaloblastic Anemias -- Chapter 42: Iron Metabolism -- Chapter 43: Iron Deficiency and Overload -- Chapter 44: Anemia Resulting from other Nutritional Deficiencies -- Chapter 45: Anemia Associated with Marrow Infiltration -- Chapter 46: Erythrocyte Membrane Disorders -- Chapter 47: Erythrocyte Enzyme Disorders -- Chapter 48: The Thalassemias: Disorders of Globin Synthesis -- Chapter 49: Disorders of Hemoglobin Structure: Sickle Cell Anemia and Related Abnormalities -- Chapter 50: Methemoglobinemia and Other Dyshemoglobinemias -- Chapter 51: Fragmentation Hemolytic Anemia -- Chapter 52: Erythrocyte Disorders as a Result of Chemical and Physical Agents -- Chapter 53: Hemolytic Anemia Resulting from Infections with Microorganisms -- Chapter 54: Hemolytic Anemia Resulting from Immune Injury -- Chapter 55: Alloimmune Hemolytic Disease of the Fetus and Newborn -- Chapter 56: Hypersplenism and Hyposplenism -- Chapter 57: Primary and Secondary Erythrocytoses -- Chapter 58: The Porphyrias -- Chapter 59: Polyclonal and Hereditary Sideroblastic Anemias -- Part VII: Neutrophils, Eosinophils, Basophils, and Mast Cells -- Chapter 60: Structure and Composition of Neutrophils, Eosinophils, and Basophils -- Chapter 61: Production, Distribution, and Fate of Neutrophils -- Chapter 62: Eosinophils and Related Disorders.
0071833005 (printISBN) 9780071833004 (print-ISBN)
2015020062
Blood --Diseases.
Hematologic Diseases.
Hematology --methods.
Hematology.
Hematologic Diseases.
Hematology/methods.
RC633 / .H43 2015
616.1/5
WH 100
"A Lange medical book." Preceded by Williams hematology / editors, Kenneth Kaushansky... [et al.]. 8th ed. c2010.
Includes bibliographical references and indexes.
Chapter 63: Basophils, Mast Cells, and Related Disorders -- Chapter 64: Classification and Clinical Manifestations of Neutrophil Disorders -- Chapter 65: Neutropenia and Neutrophilia -- Chapter 66: Disorders of Neutrophil Function -- Part VIII: Monocytes and Macrophages -- Chapter 67: Structure, Receptors, and Functions of Monocytes and Macrophages -- Chapter 68: Production, Distribution, and Activation of Monocytes and Macrophages -- Chapter 69: Classification and Clinical Manifestations of Disorders of Monocytes and Macrophages -- Chapter 70: Monocytosis and Monocytopenia -- Chapter 71: Inflammatory and Malignant Histiocytosis -- Chapter 72: Gaucher Disease and Related Lysosomal Storage Diseases -- Part IX: Lymphocytes and Plasma Cells -- Chapter 73: The Structure of Lymphocytes and Plasma Cells -- Chapter 74: Lymphopoiesis -- Chapter 75: Functions of B Lymphocytes and Plasma Cells in Immunoglobulin Production -- Chapter 76: Functions of Tlymphocytes: T-Cell Receptors for Antigen -- Chapter 77: Functions of Natural Killer Cells -- Chapter 78: Classification and Clinical Manifestations of Lymphocyte and Plasma Cell Disorders -- Chapter 79: Lymphocytosis and Lymphocytopenia -- Chapter 80: Immunodeficiency Diseases -- Chapter 81: Hematologic Manifestations of Acquired Immunodeficiency Syndrome -- Chapter 82: Mononucleosis Syndromes -- Part X: Malignant Myeloid Diseases -- Chapter 83: Classification and Clinical Manifestations of the Clonal Myeloid Disorders -- Chapter 84: Polycythemia Vera -- Chapter 85: Essential Thrombocythemia -- Chapter 86: Primary Myelofibrosis -- Chapter 87: Myelodysplastic Syndromes -- Chapter 88: Acute Myelogenous Leukemia -- Chapter 89: Chronic Myelogenous Leukemia and Related Disorders -- Part XI: Malignant Lymphoid Diseases -- Chapter 90: Classification of Malignant Lymphoid Disorders -- Chapter 91: Acute Lymphoblastic Leukemia -- Chapter 92: Chronic Lymphocytic Leukemia -- Chapter 93: Hairy Cell Leukemia -- Chapter 94: Large Granular Lymphocytic Leukemia -- Chapter 95: General Considerations for Lymphomas: Epidemiology, Etiology, Heterogeneity, and Primary Extranodal Disease -- Chapter 96: Pathology of Lymphomas -- Chapter 97: Hodgkin Lymphoma -- Chapter 98: Diffuse Large B-Cell Lymphoma and Related Diseases -- Chapter 99: Follicular Lymphoma -- Chapter 100: Mantle Cell Lymphoma -- Chapter 101: Marginal Zone B-Cell Lymphomas -- Chapter 102: Burkitt Lymphoma -- Chapter 103: Cutaneous T-Cell Lymphoma (Mycosis Fungoides and SéZary Syndrome) -- Chapter 104: Mature T-Cell and Natural Killer Cell Lymphomas -- Chapter 105: Plasma Cell Neoplasms: General Considerations -- Chapter 106: Essential Monoclonal Gammopathy -- Chapter 107: Myeloma -- Chapter 108: Immunoglobulin Light-Chain Amyloidosis -- Chapter 109: Macroglobulinemia -- Chapter 110: Heavy-Chain Disease -- Part XII: Hemostasis and Thrombosis -- Chapter 111: Megakaryopoiesis and Thrombopoiesis -- Chapter 112: Platelet Morphology, Biochemistry, and Function -- Chapter 113: Molecular Biology and Biochemistry of the Coagulation Factors and Pathways of Hemostasis -- Chapter 114: Control of Coagulation Reactions -- Chapter 115: Vascular Function in Hemostasis -- Chapter 116: Classification, Clinical Manifestations, and Evaluation of Disorders of Hemostasis -- Chapter 117: Thrombocytopenia -- Chapter 118: Heparin-Induced Thrombocytopenia -- Chapter 119: Reactive Thrombocytosis -- Chapter 120: Hereditary Qualitative Platelet Disorders -- Chapter 121: Acquired Qualitative Platelet Disorders -- Chapter 122: The Vascular Purpuras -- Chapter 123: Hemophilia A and Hemophilia B -- Chapter 124: Inherited Deficiencies of Coagulation Factors II, V, V+VIII, VII, X, XI, and XIII -- Chapter 125: Hereditary Fibrinogen Abnormalities -- Chapter 126: Von Willebrand Disease -- Chapter 127: Antibody-Mediated Coagulation Factor Deficiencies -- Chapter 128: Hemostatic Alterations in Liver Disease and Liver Transplantation -- Chapter 129: Disseminated Intravascular Coagulation -- Chapter 130: Hereditary Thrombophilia -- Chapter 131: The Antiphospholipid Syndrome -- Chapter 132: Thrombotic Microangiopathies -- Chapter 133: Venous Thrombosis -- Chapter 134: Atherothrombosis: Disease Initiation, Progression, and Treatment -- Chapter 135: Fibrinolysis and Thrombolysis -- Part XIII: Transfusion Medicine -- Chapter 136: Erythrocyte Antigens and Antibodies -- Chapter 137: Human Leukocyte and Platelet Antigens -- Chapter 138: Blood Procurement and Red Cell Transfusion -- Chapter 139: Preservation and Clinical Use of Platelets. Part I: Clinical Evaluation of the Patient -- Chapter 1: Initial Approach to the Patient: History and Physical Examination -- Chapter 2: Examination of Blood Cells -- Chapter 3: Examination of the Marrow -- Chapter 4: Consultative Hematology -- Part II: The Organization of the Lymphohematopoietic Tissues -- Chapter 5: Structure of the Marrow and the Hematopoietic Microenvironment -- Chapter 6: The Organization and Structure of Lymphoid Tissues -- Part III: Epochal Hematology -- Chapter 7: Hematology of the Fetus and Newborn -- Chapter 8: Hematology During Pregnancy -- Chapter 9: Hematology in Older Persons -- Part IV: Molecular and Cellular Hematology -- Chapter 10: Genetic Principles and Molecular Biology -- Chapter 11: Genomics -- Chapter 12: Epigenetics -- Chapter 13: Cytogenetics and Genetic Abnormalities -- Chapter 14: Metabolism of Hematologic Neoplastic Cells -- Chapter 15: Apoptosis Mechanisms: Relevance to the Hematopoietic System -- Chapter 16: Cell-Cycle Regulation and Hematologic Disorders -- Chapter 17: Signal Transduction Pathways -- Chapter 18: Hematopoietic Stem Cells, Progenitors, and Cytokines -- Chapter 19: The Inflammatory Response -- Chapter 20: Innate Immunity -- Chapter 21: Dendritic Cells and Adaptive Immunity -- Part V: Therapeutic Principles -- Chapter 22: Pharmacology and Toxicity of Antineoplastic Drugs -- Chapter 23: Hematopoietic Cell Transplantation -- Chapter 24: Treatment of Infections in the Immunocompromised Host -- Chapter 25: Principles of Antithrombotic Therapy -- Chapter 26: Immune Cell Therapy -- Chapter 27: Vaccine Therapy -- Chapter 28: Therapeutic Apheresis: Indications, Efficacy, and Complications -- Chapter 29: Gene Therapy for Hematologic Diseases -- Chapter 30: Regenerative Medicine: Multipotential Cell Therapy for Tissue Repair -- Part VI: The Erythrocyte -- Chapter 31: Structure and Composition of the Erythrocyte -- Chapter 32: Erythropoiesis -- Chapter 33: Erythrocyte Turnover -- Chapter 34: Clinical Manifestations and Classification of Erythrocyte Disorders -- Chapter 35: Aplastic Anemia: Acquired and Inherited -- Chapter 36: Pure Red Cell Aplasia -- Chapter 37: Anemia of Chronic Disease -- Chapter 38: Erythropoietic Effects of Endocrine Disorders -- Chapter 39: The Congenital Dyserythropoietic Anemias -- Chapter 40: Paroxysmal Nocturnal Hemoglobinuria -- Chapter 41: Folate, Cobalamin, and Megaloblastic Anemias -- Chapter 42: Iron Metabolism -- Chapter 43: Iron Deficiency and Overload -- Chapter 44: Anemia Resulting from other Nutritional Deficiencies -- Chapter 45: Anemia Associated with Marrow Infiltration -- Chapter 46: Erythrocyte Membrane Disorders -- Chapter 47: Erythrocyte Enzyme Disorders -- Chapter 48: The Thalassemias: Disorders of Globin Synthesis -- Chapter 49: Disorders of Hemoglobin Structure: Sickle Cell Anemia and Related Abnormalities -- Chapter 50: Methemoglobinemia and Other Dyshemoglobinemias -- Chapter 51: Fragmentation Hemolytic Anemia -- Chapter 52: Erythrocyte Disorders as a Result of Chemical and Physical Agents -- Chapter 53: Hemolytic Anemia Resulting from Infections with Microorganisms -- Chapter 54: Hemolytic Anemia Resulting from Immune Injury -- Chapter 55: Alloimmune Hemolytic Disease of the Fetus and Newborn -- Chapter 56: Hypersplenism and Hyposplenism -- Chapter 57: Primary and Secondary Erythrocytoses -- Chapter 58: The Porphyrias -- Chapter 59: Polyclonal and Hereditary Sideroblastic Anemias -- Part VII: Neutrophils, Eosinophils, Basophils, and Mast Cells -- Chapter 60: Structure and Composition of Neutrophils, Eosinophils, and Basophils -- Chapter 61: Production, Distribution, and Fate of Neutrophils -- Chapter 62: Eosinophils and Related Disorders.
0071833005 (printISBN) 9780071833004 (print-ISBN)
2015020062
Blood --Diseases.
Hematologic Diseases.
Hematology --methods.
Hematology.
Hematologic Diseases.
Hematology/methods.
RC633 / .H43 2015
616.1/5
WH 100